December 19, 2017
Article
Denise A. Yardley, MD, discusses the promise of CDK4&6 inhibitors in estrogen receptor (ER)-positive breast cancer, as well as the potential with immunotherapy agents.
November 29, 2017
Article
Laura J. van’t Veer, PhD, discusses determining more accurate methods of treatment for patients with early- and late-stage breast cancer based on advances in genetic testing, specifically the 70-gene prognostic signature.
November 03, 2017
Article